Combs Andrew

Chief Chemistry Officer at Prelude Therapeutics Inc · on record since Sep 29, 2020

Insider trading activity of Combs Andrew

Transactions on record: 14; since Sep 29, 2020

Open-market buys: 6; $268.6K

Open-market sells: 0

Companies traded: 1; last filing Feb 5, 2026

Figures computed from official regulatory filings — .

Companies where Combs Andrew has traded

Prelude Therapeutics Inc14 tx · $336.8K · Feb 5, 2026

Track record of Combs Andrew

Statistical track record

Free account

Open-market buys: 6

Last buy: Mar 25, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of Combs Andrew

Co-insiders of Combs Andrew

667, L.P.Prelude Therapeutics Inc
Babler MartinPrelude Therapeutics Inc
Baker Bros. Advisors (GP) LLCPrelude Therapeutics Inc
BAKER BROS. ADVISORS LPPrelude Therapeutics Inc
Baker Brothers Life Sciences LPPrelude Therapeutics Inc
BAKER FELIXPrelude Therapeutics Inc
BAKER JULIANPrelude Therapeutics Inc
Bonita David PPrelude Therapeutics Inc
Brusky Sean P.Prelude Therapeutics Inc
Chardonnet LaurentPrelude Therapeutics Inc
Dier MardiPrelude Therapeutics Inc
Dorton KatinaPrelude Therapeutics Inc
FRIEDMAN PAUL APrelude Therapeutics Inc

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Prelude Therapeutics IncListing on record	Feb 5, 2026	AwardD (derivative)	230,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Mar 27, 2025	Buy	100,000	0.69 USD	$69K	conv 53	SEC
Prelude Therapeutics IncListing on record	Feb 5, 2025	AwardD (derivative)	175,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Dec 26, 2024	Buy	3,075	1.15 USD	$3.5K	conv 56ClusterUnusual size+1	SEC
Prelude Therapeutics IncListing on record	Dec 26, 2024	Buy	60,000	1.37 USD	$82.2K	conv 67ClusterUnusual size	SEC
Prelude Therapeutics IncListing on record	Mar 4, 2024	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Feb 9, 2023	AwardD (derivative)	135,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Apr 4, 2022	ExerciseD (derivative)	-36,062	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Apr 4, 2022	Exercise	36,062	1.89 USD	$68.2K		SEC
Prelude Therapeutics IncListing on record	Feb 17, 2022	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Dec 15, 2021	Buy	4,000	12.12 USD	$48.5K	conv 54First in 12mo	SEC
Prelude Therapeutics IncListing on record	Dec 15, 2021	Buy	4,000	11.60 USD	$46.4K	conv 38	SEC
Prelude Therapeutics IncListing on record	Jul 22, 2021	AwardD (derivative)	95,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Sep 29, 2020	Buy	1,000	19.00 USD	$19K	conv 51ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Prelude Therapeutics IncListing on record	Feb 5, 2026	AwardD (derivative)	230,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Mar 27, 2025	Buy	100,000	0.69 USD	$69K	conv 53	SEC
Prelude Therapeutics IncListing on record	Feb 5, 2025	AwardD (derivative)	175,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Dec 26, 2024	Buy	3,075	1.15 USD	$3.5K	conv 56ClusterUnusual size+1	SEC
Prelude Therapeutics IncListing on record	Dec 26, 2024	Buy	60,000	1.37 USD	$82.2K	conv 67ClusterUnusual size	SEC
Prelude Therapeutics IncListing on record	Mar 4, 2024	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Feb 9, 2023	AwardD (derivative)	135,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Apr 4, 2022	ExerciseD (derivative)	-36,062	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Apr 4, 2022	Exercise	36,062	1.89 USD	$68.2K		SEC
Prelude Therapeutics IncListing on record	Feb 17, 2022	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Dec 15, 2021	Buy	4,000	12.12 USD	$48.5K	conv 54First in 12mo	SEC
Prelude Therapeutics IncListing on record	Dec 15, 2021	Buy	4,000	11.60 USD	$46.4K	conv 38	SEC
Prelude Therapeutics IncListing on record	Jul 22, 2021	AwardD (derivative)	95,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Prelude Therapeutics IncListing on record	Sep 29, 2020	Buy	1,000	19.00 USD	$19K	conv 51ClusterFirst in 12mo	SEC